Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial
- Adrienne G. Waks
- Jingxin Fu
- Xiangying Chu
- Busem Binboga Kurt
- Tianyu Li
- Thomas M. Kuntz
- Yizhuo Shen
- David Yang
- Kevin Meli
- Brendan Reardon
- Jihye Park
- Ann Partridge
- Daniel Abravanel
- Rinath Jeselsohn
- Eileen Wrabel
- Jillian Alberti
- Molly DiLullo
- Serenity Chen
- Ayesha Mohammed-Abreu
- Xiaopeng Sun
- Justin M. Balko
- Miranda Kleijn
- William Audeh
- Xochitl C. Morgan
- Ian E. Krop
- Nabihah Tayob
- Eliezer M. Van Allen
- Elizabeth A. Mittendorf
- Sara M. Tolaney
2025-11-28